Lili Zhang

2PUBLICATIONS
5CO-AUTHORS
Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (2)

|Feb 17, 2026
Phase II trial of anlotinib-chemotherapy combination in pretreated HER2-negative metastatic breast cancer: therapeutic efficacy and proteomic biomarker profiling.

Ting Xu, Quan Gu, Shiyi Li

|Jan 01, 2025
The Effects of Anlotinib Combined with Chemotherapy following Progression on Cyclin-Dependent Kinase 4/6 Inhibitor in Hormone Receptor-Positive Metastatic Breast Cancer.

Ting Xu, Weili Xiong, Lili Zhang

Pageof 1

Frequent Collaborators

2 joint publications

Ting Xu

2 joint publications

Yuan Yuan

1 joint publications

Weili Xiong

1 joint publications

Quan Gu